Disclaimer: DiscoVari is currently designed as a research tool and should not be used clinically as a diagnostic tool.
DiscoVari has been validated for missense variants in arrhythmogenic cardiomyopathy (PKP2, DSC2, DSG2, DSP), catecholaminergic polymorphic ventricular tachycardia (RYR2), long QT syndrome (KCNQ1, KCNH2, SCN5A), and hypertrophic cardiomyopathy (MYH7, MYBPC3, TNNT2, TNNI3, ACTC1, TPM1, MYL2, MYL3). It has been validated for cardiomyopathy-associated truncating variants in TTN.
Further validation is needed prior to its incorporation into clinical variant interpretation and decision making.